<DOC>
	<DOCNO>NCT00997724</DOCNO>
	<brief_summary>The purpose study examine feasibility assisted-VATS ( video-assisted thoracoscopic surgery ) sleeve lobectomy non-small cell lung cancer non-small cell lung cancer . Success define assisted-VATS sleeve lobectomy without conversion . If success rate 90 % , assisted-VATS sleeve lobectomy consider feasible procedure non-small cell lung cancer .</brief_summary>
	<brief_title>Assisted-VATS Sleeve Lobectomy Non-small Cell Lung Cancer</brief_title>
	<detailed_description>Sleeve lobectomy removal portion main stem bronchus continuity adjacent lobe bilobe follow end-to-end bronchial anastomosis . The first report bronchial sleeve resection perform 1947 Brompton Hospital London , England , Sir Clement Price Thomas . Whether sleeve resection radical enough indicated patient could tolerate pneumonectomy continue debate , although many recent report suggest sleeve resection achieve adequate curability rate . However , sleeve lobectomy definite role surgical management lung cancer patient whose pulmonary reserve consider inadequate permit pneumonectomy , use anytime possible achieve margin-negative ( R0 ) resection . Although video-assisted thoracic surgery ( VATS ) regard minimally invasive procedure good long-term survival result , many surgeon think VATS complex many technical limitation apply bronchoplasty . Therefore , report literature VATS bronchoplasty lung cancer . The purpose study examine feasibility assisted-VATS ( video-assisted thoracoscopic surgery ) sleeve lobectomy non-small cell lung cancer non-small cell lung cancer . Success define assisted-VATS sleeve lobectomy without conversion . If success rate 90 % , assisted-VATS sleeve lobectomy consider feasible procedure non-small cell lung cancer .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Histologically confirm nonsmall cell lung cancer ( Squamous , adenosquamous , large cell , poorly differentiate ) Patients central tumor locate origin lobar bronchus . ECOG performance status 01 Hematopoietic : WBC least 4,000/mm^3 ; Platelet count least 100,000/mm^3 Hepatic : Bilirubin normal ; AST/ALT great 1.5 time upper limit normal ( ULN ) ; Alkaline phosphatase great 2.5 time ULN Renal : Creatinine clearance great 60 ml/min Cardiovascular : Cardiac function normal Severe complication infection Pregnant breastfeed woman Clinically significant heart disease Uncontrolled hepatitis , chronic liver disease , diabetes mellitus Another active cancer except properly treat carcinoma situ cervix basal/squamous cell skin carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>assisted-VATS ( video-assisted thoracoscopic surgery )</keyword>
	<keyword>sleeve lobectomy</keyword>
	<keyword>bronchoplasty</keyword>
</DOC>